Evogene Ltd Ord (EVGN) Stock Price, Quote & News

Company Profile

Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally. The company focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through its computational predictive biology (CPB) platform. It operates through three segments: Agriculture, Human Health, and other Industrial Applications. The Agriculture segmen...

Industry: Biotechnology

Sector: Healthcare

Phone: 972 8 931 1900

Fax: 972 8 946 6724

Website: www.evogene.com

Address:

13 Gad Feinstein Street, Park Rehovot, Rehovot, Israel

WastedJake Mar. 20 at 7:54 PM

$EVGN im in

0 · Reply

STOCKSGambino Mar. 20 at 4:46 PM

$EVGN

0 · Reply

RiZzBoTt Mar. 19 at 5:18 PM

$EVGN If @STOCKSGambino is in, im definitely in. As always do your own research.

0 · Reply

KAMIKAZ3TIGER Mar. 19 at 5:07 PM

$EVGN $5 in 2026!!!

0 · Reply

STOCKSGambino Mar. 19 at 4:19 PM

$EVGN https://x.com/StocksGambino/status/2034665876293640429

1 · Reply

STOCKSGambino Mar. 19 at 2:48 PM

$EVGN Reminder EVGN has this next week; - ''Oral presentation titled "Drug Discovery and Development: Evogene" scheduled for March 24, 2026, 15:30–15:45 WET. Evogene Ltd. will present its pharma discovery achievements at the BIO-Europe Spring 2026 conference in Lisbon.'' they started their 2nd collab with Google in Feb so they will prob mention Google again; - ''Successful collaboration with Google Cloud, leading to a second collaboration to integrate advanced AI agents.''

0 · Reply

suntanner20 Mar. 19 at 12:24 PM

$EVGN Casterra.co is 100% owned by Evogene. Its castor seeds for biofuel. in talks with $XOM and $CVX for full biofuel production in Brazil. OIL above 100 per bar could crush shorts to 5.00 per share $AZN + $EVGN ChempassAI = 10 per share they both have the same programs so its a natural fit.

0 · Reply

STOCKSGambino Mar. 18 at 2:45 PM

$EVGN https://x.com/StocksGambino/status/2034279845866144251

0 · Reply

PositivityPilled Mar. 17 at 7:02 PM

$EVGN can someone tell me where it all went wrong because I want to hop back in but if it’s a dilution machine now I rather not

2 · Reply

PositivityPilled Mar. 17 at 7:00 PM

$EVGN I sold most of my shares here a long time ago but I decided to hold 2 shares because I don’t want to close my investors edge account and I’m required to hold stocks in there

0 · Reply

Evogene Ltd (EVGN) Q4 2025 Earnings Call Highlights: Strategic Shifts Amid Revenue Decline

2026-03-13T23:50:52.000Z - 8 days ago

Q4 2025 Evogene Ltd Earnings Call Transcript

Mon, 09 Mar 2026 09:00:00 -0400 - 12 days ago

Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026

2026-03-05T12:41:07.000Z - 16 days ago

Evogene (EVGN) Focuses on Key Markets Following Strategic Shift

2026-03-05T12:10:35.000Z - 16 days ago

Evogene Earnings Review: Q4 Summary

Thu, 05 Mar 2026 07:00:00 -0500 - 16 days ago

Evogene Reports Fourth Quarter and Full Year 2025 Financial Results

2026-03-04T19:01:57.000Z - 17 days ago

An Overview of Evogene's Earnings

Wed, 25 Feb 2026 08:00:00 -0500 - 24 days ago

Evogene Releases CEO Letter to Shareholders

Thu, 19 Feb 2026 08:00:00 -0500 - 4 weeks ago

Evogene Schedules Fourth Quarter and Full Year 2025 Financial Results Release

2026-02-17T13:33:51.000Z - 4 weeks ago

Evogene (EVGN) Partners with QUT to Combat Lung Cancer Drug Resistance

Tue, 17 Feb 2026 08:00:00 -0500 - 4 weeks ago

Evogene and Queensland University of Technology (QUT) Announce a Collaboration to Advance AI-Driven Cancer Therapeutics

Wed, 11 Feb 2026 08:00:00 -0500 - 5 weeks ago

Evogene, Systasy and LMU University Hospital Munich Announce a Collaboration to Develop Novel Therapies for Neutrophil-Derived Inflammatory Diseases

Tue, 10 Feb 2026 13:20:00 -0500 - 5 weeks ago

Evogene Announces a Warrant Inducement Transaction for Approximately $3.4 Million of Gross Proceeds

2026-02-10T13:29:55.000Z - 5 weeks ago

Evogene (EVGN) Expands Collaboration with Google Cloud to Boost AI Capabilities

Tue, 10 Feb 2026 08:00:00 -0500 - 5 weeks ago

Evogene Announces Expanded Collaboration with Google Cloud to Integrate AI Agents into ChemPass AI™

Mon, 09 Feb 2026 08:00:00 -0500 - 5 weeks ago

Evogene Appoints Prof. John Irwin and Prof.

2026-02-05T11:26:12.000Z - 6 weeks ago

Evogene (EVGN) Subsidiary Biomica Secures Licensing Deal for Innovative Cancer Therapy

Wed, 04 Feb 2026 22:00:00 -0500 - 6 weeks ago

Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung Cancer

2026-02-04T13:41:08.000Z - 6 weeks ago

Evogene (EVGN) Signs Licensing Agreement for Promising Cancer Therapy

2026-01-07T12:30:48.000Z - 2 months ago

Evogene (EVGN) and Unravel Biosciences Partner to Tackle Neurological Diseases

Wed, 07 Jan 2026 07:00:00 -0500 - 2 months ago

Evogene and Unravel Biosciences Announce Collaboration to Develop a First-in-Class Therapy to Reverse Neurological Damage in Demyelinating Disorders

Tue, 30 Dec 2025 07:00:00 -0500 - 2 months ago

Evogene Announces Appointment of Dr. Olga Nissan as its Vice President of Business Development

Thu, 20 Nov 2025 07:00:00 -0500 - 4 months ago

Evogene Reports Third Quarter 2025 Financial Results

2025-11-19T16:03:33.000Z - 4 months ago

What's Next: Evogene's Earnings Preview

Tue, 11 Nov 2025 07:00:00 -0500 - 4 months ago

Casterra and Fantini Partner to Advance Agricultural Mechanization for Scalable Commercial Castor Farming

Thu, 06 Nov 2025 09:00:00 -0500 - 4 months ago

Evogene Schedules Third Quarter 2025 Financial Results Release

Thu, 28 Aug 2025 07:00:00 -0400 - 7 months ago

Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference in New York

Tue, 19 Aug 2025 07:00:00 -0400 - 7 months ago

Evogene Reports Second Quarter 2025 Financial Results

2025-08-18T15:02:56.000Z - 7 months ago

Preview: Evogene's Earnings

Tue, 12 Aug 2025 07:00:00 -0400 - 7 months ago

Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases

Tue, 29 Jul 2025 07:00:00 -0400 - 8 months ago

Evogene Schedules Second Quarter 2025 Financial Results Release

Tue, 08 Jul 2025 07:00:00 -0400 - 9 months ago

Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL

Tue, 10 Jun 2025 07:00:00 -0400 - 10 months ago

Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud

Wed, 21 May 2025 07:00:00 -0400 - 10 months ago

Evogene Reports First Quarter 2025 Financial Results

2025-05-20T15:02:35.000Z - 10 months ago

Insights into Evogene's Upcoming Earnings

Thu, 08 May 2025 07:00:00 -0400 - 11 months ago

Evogene Schedules First Quarter 2025 Financial Results Release

Mon, 21 Apr 2025 07:00:00 -0400 - 11 months ago

ICL to Acquire the Activity of Evogene's Subsidiary, Lavie Bio

Mar 6, 2025, 7:15 AM EST - 1 year ago

Evogene Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 6, 2025, 7:00 AM EST - 1 year ago

Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025

Feb 20, 2025, 7:00 AM EST - 1 year ago

Evogene Schedules Fourth Quarter 2024 Financial Results Release

Feb 13, 2025, 8:00 AM EST - 1 year ago

AgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat Disease

Nov 21, 2024, 7:30 AM EST - 1 year ago

Evogene Reports Third Quarter 2024 Financial Results

Nov 19, 2024, 7:00 AM EST - 1 year ago

Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results

Nov 12, 2024, 7:00 AM EST - 1 year ago

Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials

Nov 7, 2024, 7:00 AM EST - 1 year ago

Evogene Schedules Third Quarter 2024 Financial Results Release

Oct 31, 2024, 8:00 AM EDT - 1 year ago

Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design

Oct 29, 2024, 8:00 AM EDT - 1 year ago

Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya

Oct 8, 2024, 7:00 AM EDT - 1 year ago

Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology

Sep 30, 2024, 7:00 AM EDT - 1 year ago

Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals

Aug 23, 2024, 8:55 AM EDT - 1 year ago

Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement

Aug 22, 2024, 7:00 AM EDT - 1 year ago

Evogene Reports Second Quarter 2024 Financial Results

Aug 12, 2024, 7:11 AM EDT - 1 year ago

Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

Aug 12, 2024, 7:00 AM EDT - 1 year ago

Evogene Schedules Second Quarter 2024 Financial Results Release

Jul 31, 2024, 7:00 AM EDT - 1 year ago

Casterra Announces the Completion of a Successful Castor Seed Growing and Harvesting Season in Brazil

Jul 23, 2024, 8:48 AM EDT - 1 year ago

Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split

Jul 17, 2024, 8:00 AM EDT - 1 year ago

ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants

ICL

Jul 2, 2024, 7:00 AM EDT - 1 year ago

Lavie Bio Announces Commercial Expansion of Yalos™ to Winter Wheat

Jun 25, 2024, 7:00 AM EDT - 1 year ago

Casterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African Country

$Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma$

May 23, 2024, 11:00 AM EDT - 1 year ago

Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma

May 23, 2024, 7:00 AM EDT - 1 year ago

Evogene Reports First Quarter 2024 Financial Results

May 21, 2024, 7:03 AM EDT - 1 year ago

Casterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor Seeds

May 9, 2024, 7:00 AM EDT - 2 years ago

Evogene Schedules First Quarter 2024 Financial Results Release

Apr 16, 2024, 7:00 AM EDT - 2 years ago

Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting

WastedJake Mar. 20 at 7:54 PM

$EVGN im in

0 · Reply

STOCKSGambino Mar. 20 at 4:46 PM

$EVGN

0 · Reply

RiZzBoTt Mar. 19 at 5:18 PM

$EVGN If @STOCKSGambino is in, im definitely in. As always do your own research.

0 · Reply

KAMIKAZ3TIGER Mar. 19 at 5:07 PM

$EVGN $5 in 2026!!!

0 · Reply

STOCKSGambino Mar. 19 at 4:19 PM

$EVGN https://x.com/StocksGambino/status/2034665876293640429

1 · Reply

STOCKSGambino Mar. 19 at 2:48 PM

0 · Reply

suntanner20 Mar. 19 at 12:24 PM

0 · Reply

STOCKSGambino Mar. 18 at 2:45 PM

$EVGN https://x.com/StocksGambino/status/2034279845866144251

0 · Reply

PositivityPilled Mar. 17 at 7:02 PM

$EVGN can someone tell me where it all went wrong because I want to hop back in but if it’s a dilution machine now I rather not

2 · Reply

PositivityPilled Mar. 17 at 7:00 PM

$EVGN I sold most of my shares here a long time ago but I decided to hold 2 shares because I don’t want to close my investors edge account and I’m required to hold stocks in there

0 · Reply

STOCKSGambino Mar. 17 at 6:36 PM

$EVGN they will 100% mention/PR about working with google again in the conference next week

1 · Reply

STOCKSGambino Mar. 17 at 6:33 PM

$EVGN

0 · Reply

suntanner20 Mar. 17 at 4:56 PM

$EVGN owns 100% OF Casterra biofuel from castor seeds they are working with I believe to be $XOM $CVX in Brazil along with other plastic rubber sole OEMs to use their castor seeds oil hits 112+++ someone will buy Casterra outright for 20m-30m ??

0 · Reply

STOCKSGambino Mar. 17 at 3:53 PM

$EVGN EVGN x Google $GOOG

0 · Reply

STOCKSGambino Mar. 17 at 3:30 PM

$EVGN

0 · Reply

STOCKSGambino Mar. 17 at 3:29 PM

$EVGN

0 · Reply

STOCKSGambino Mar. 16 at 2:32 PM

$EVGN ''Biomica anticipates distributing the majority of its remaining cash to its shareholders, including Evogene.''

0 · Reply

STOCKSGambino Mar. 13 at 5:00 PM

$EVGN https://x.com/StocksGambino/status/2032501573834703167

0 · Reply

STOCKSGambino Mar. 13 at 4:11 PM

$EVGN https://x.com/StocksGambino/status/2032489387854827909

0 · Reply

STOCKSGambino Mar. 13 at 3:02 PM

$EVGN

0 · Reply

STOCKSGambino Mar. 13 at 2:59 PM

$EVGN good dip opp at 5min 200ma right now if you want to add for swing

0 · Reply

STOCKSGambino Mar. 13 at 2:06 AM

$EVGN https://x.com/StocksGambino/status/2032275775575978361

0 · Reply

Market Cap	4.54M
Revenue (ttm)	3.85M
Net Income (ttm)	-8.49M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-220.52%
Debt to Equity Ratio	0.00

Volume	95,500
Avg Vol	555,858
Day's Range	N/A - N/A
Shares Out	5.37M
Stochastic %K	66%
Beta	1.36
Analysts	Strong Buy
Price Target	$1.75